Key result
Idarucizumab for dabigatran overdose was discussed in an author reply to correspondence regarding a previously published case report.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Does not support routine idarucizumab use in dabigatran overdose; leaves open need for prospective evaluation.
"Answer by the authors to the letter of Dr. Wang and colleagues, concerning our case report entitled “Idarucizumab for dabigatran overdose”." Clinical Toxicology, 55(1), p. 66
No takes yet. Share an insight, caveat, or question.
Peetermans et al. (2016) studied this question. Idarucizumab for dabigatran overdose was discussed in an author reply to correspondence regarding a previously published case report.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: